Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy

View through CrossRef
Abstract   Modern glycemic monitoring systems make it easier for doctors and nurses to manage diabetic patients on intravenous insulin therapy in hospital wards and intensive care units (ICU). But one of the most important questions - is it safe for inpatients and usable and cost-effective for hospitals?In our study, we included 1,684 glucometer measurements and 72 cycles (1 cycle = 6 days) of the glycemic monitoring system (Guardian Connect Enlite, Medtronic) in patients on intravenous insulin therapy. Most of them were after pancreatectomy. The mean discrepancy between CGM and glucometer values was -4.1%. According to our study, 77.48% of patients were within the target glycemic range (77.4 mg/dL to 189 mg/dL / 4.3 mmol/L to 10.5 mmol/L), hypoglycemia below 50.4 mg/dL / 2.3 mmol/L was recorded in only 2 cases out of 1648. Results confirm safety and usefulness of glucose monitoring systems in-hospital even in the most severe patients, such as those who were in several days after total pancreatectomy. We compared the cost glucose control using of CGM during of one cycle (6 days) and cost glucose control using glucometer during the same period (6 days) for diabetic patients on intravenous insulin therapy in the inpatient department. We account the cost of the CGM system, batteries, smartphone, glucometer, lancets, test strips, sensors, gloves, antiseptic wipes. Results 6 days glucose control for diabetic patients on intravenous insulin therapy of using CGM (including 3 times a day using glucometer for calibration of CGM) cost 5422 rubles (68.2 $ / 62.7 €), using only glucometer (18 times a day) cost 6696 rubles. But the most interesting results were after comparing the nurse's time, spent on the glucose control for diabetic patients on intravenous insulin therapy. During 6 days of using of CGM for this patients nurse spends (including 3 times a day using glucometer for calibration of CGM) - 71 minutes. During 6 days of using only glucometer (18 times a day) for this patients nurse spends - 324 minutes. In that way using of CGM for diabetic patients on intravenous insulin therapy save for nurse 253 minutes (nearly 4 hours) during 6 days. The cost of 1 hour of nurse for private hospitals in Moscow in ICU an average 661 rubles (8.3 $ / 7.65 €), in inpatient department - 544 rubles (6.85 $ / 6.3 €). In finally results show a significant cost-effective of using CGM. Nevertheless, well-known the other one of the most important benefit of using CGM devices is that glycemic control with CGM systems improves the quality of life of patients, because no routine finger pricking is required. Presentation: No date and time listed
Title: LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
Description:
Abstract   Modern glycemic monitoring systems make it easier for doctors and nurses to manage diabetic patients on intravenous insulin therapy in hospital wards and intensive care units (ICU).
But one of the most important questions - is it safe for inpatients and usable and cost-effective for hospitals?In our study, we included 1,684 glucometer measurements and 72 cycles (1 cycle = 6 days) of the glycemic monitoring system (Guardian Connect Enlite, Medtronic) in patients on intravenous insulin therapy.
Most of them were after pancreatectomy.
The mean discrepancy between CGM and glucometer values was -4.
1%.
According to our study, 77.
48% of patients were within the target glycemic range (77.
4 mg/dL to 189 mg/dL / 4.
3 mmol/L to 10.
5 mmol/L), hypoglycemia below 50.
4 mg/dL / 2.
3 mmol/L was recorded in only 2 cases out of 1648.
Results confirm safety and usefulness of glucose monitoring systems in-hospital even in the most severe patients, such as those who were in several days after total pancreatectomy.
We compared the cost glucose control using of CGM during of one cycle (6 days) and cost glucose control using glucometer during the same period (6 days) for diabetic patients on intravenous insulin therapy in the inpatient department.
We account the cost of the CGM system, batteries, smartphone, glucometer, lancets, test strips, sensors, gloves, antiseptic wipes.
Results 6 days glucose control for diabetic patients on intravenous insulin therapy of using CGM (including 3 times a day using glucometer for calibration of CGM) cost 5422 rubles (68.
2 $ / 62.
7 €), using only glucometer (18 times a day) cost 6696 rubles.
But the most interesting results were after comparing the nurse's time, spent on the glucose control for diabetic patients on intravenous insulin therapy.
During 6 days of using of CGM for this patients nurse spends (including 3 times a day using glucometer for calibration of CGM) - 71 minutes.
During 6 days of using only glucometer (18 times a day) for this patients nurse spends - 324 minutes.
In that way using of CGM for diabetic patients on intravenous insulin therapy save for nurse 253 minutes (nearly 4 hours) during 6 days.
The cost of 1 hour of nurse for private hospitals in Moscow in ICU an average 661 rubles (8.
3 $ / 7.
65 €), in inpatient department - 544 rubles (6.
85 $ / 6.
3 €).
In finally results show a significant cost-effective of using CGM.
Nevertheless, well-known the other one of the most important benefit of using CGM devices is that glycemic control with CGM systems improves the quality of life of patients, because no routine finger pricking is required.
Presentation: No date and time listed.

Related Results

Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
534-P: Evaluating the Impact of Multichannel Diabetes Care Coaching and Education in Patients New to Continuous Glucose Monitoring
534-P: Evaluating the Impact of Multichannel Diabetes Care Coaching and Education in Patients New to Continuous Glucose Monitoring
Introduction and Objective: The purpose of this study was to evaluate whether individuals with diabetes (Type 1 and Type 2) newly prescribed a continuous glucose monitor (CGM) with...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Use of Continuous Glucose Monitoring Sensors for Type 1 Diabetes Management and its Effect on Glycemic Control
Use of Continuous Glucose Monitoring Sensors for Type 1 Diabetes Management and its Effect on Glycemic Control
Objectives: To determine the frequency of use of Continuous glucose monitoring (CGM) sensors in individuals with type 1 diabetes mellitus (T1DM). To compare the levels of glycosyla...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE: To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...
Continuous Glucose Monitoring Workflows for Elderly, Cognitively Impaired Adults with Type 2 Diabetes
Continuous Glucose Monitoring Workflows for Elderly, Cognitively Impaired Adults with Type 2 Diabetes
BackgroundElderly adults with Alzheimer’s disease-related dementia (ADRD) and type 2 diabetes tend to have difficulty in detecting hypoglycemic events. Over time, recurring hypogly...
1005-P: CGM for Inpatient Glycemic Management of Type 1 Diabetes—A Remote-Monitoring Program in the Non-ICU Setting
1005-P: CGM for Inpatient Glycemic Management of Type 1 Diabetes—A Remote-Monitoring Program in the Non-ICU Setting
Introduction & Objective: There is a paucity of data on the use of continuous glucose monitoring (CGM) in real-world inpatient settings for type 1 diabetes (T1D). Using remote ...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...

Back to Top